3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Pain, Postoperative
2
Agnosia
2
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Thymoma
1
Nephrolithiasis
1
Lymphedema
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Laparoscopic Surgery
1
Kidney Neoplasms
1
Duodenal Neoplasms
1
Cerebrovascular Disorders
1
Interventions
pembrolizumab
4
enfortumab vedotin
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
tamibarotene
1
Standard of Care
1
Radiotherapy
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Nephroureterectomy
1
Morphine
1
Hyperthermia, Induced
1
Cystectomy
1
Cisplatin
1
Central Venous Catheters
1
Bupivacaine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ureteral Neoplasms
×
Bupivacaine
×
Clear all
NCT06349668
2026-02-05
SMILe
University Hospital, Linkoeping
Phase 3
Recruiting
220 enrolled